How Do Integrated Health Care Systems Address Racial and Ethnic Disparities in Colon Cancer?Posted in Articles, Health/Medicine/Genetics, Media Archive, United States on 2015-02-02 15:23Z by Steven |
How Do Integrated Health Care Systems Address Racial and Ethnic Disparities in Colon Cancer?
Journal of Clinical Oncology
Published online: 2015-01-26
DOI: 10.1200/JCO.2014.56.8642
Kim F. Rhoads, Colon and rectal surgeon, Colorectal surgeon, Surgical oncologist; Assistant Professor of Surgery at the Stanford University Medical Center
Stanford Cancer Institute
Stanford University School of Medicine
Manali I. Patel, MD
Stanford Cancer Institute
Stanford University School of Medicine
Yifei Ma, Statistician
Stanford University School of Medicine
Laura A. Schmidt, Professor of Health Policy
Philip R. Lee Institute for Health Policy Studies
University of California, San Francisco
Presented as a poster at the American Society of Clinical Oncology Quality Care Symposium, San Diego, CA, November 30-December 1, 2012.
Purpose: Colorectal cancer (CRC) disparities have persisted over the last two decades. CRC is a complex disease requiring multidisciplinary care from specialists who may be geographically separated. Few studies have assessed the association between integrated health care system (IHS) CRC care quality, survival, and disparities. The purpose of this study was to determine if exposure to an IHS positively affects quality of care, risk of mortality, and disparities.
Patients and Methods: This retrospective secondary-data analysis study, using the California Cancer Registry linked to state discharge abstracts of patients treated for colon cancer (2001 to 2006), compared the rates of National Comprehensive Cancer Network (NCCN) guideline–based care, the hazard of mortality, and racial/ethnic disparities in an IHS versus other settings.
Results: More than 30,000 patient records were evaluated. The IHS had overall higher rates of adherence to NCCN guidelines. Propensity score–matched Cox models showed an independent and protective association between care in the IHS and survival (hazard ratio [HR], 0.87; 95% CI, 0.85 to 0.90). This advantage persisted across stage groups. Black race was associated with increased hazard of mortality in all other settings (HR, 1.15; 95% CI, 1.04 to 1.27); however, there was no disparity within the IHS for any minority group (P > .11 for all groups) when compared with white race.
Conclusion: The IHS delivered higher rates of evidence-based care and was associated with lower 5-year mortality. Racial/ethnic disparities in survival were absent in the IHS. Integrated systems may serve as the cornerstone for developing accountable care organizations poised to improve cancer outcomes and eliminate disparities under health care reform.
Read or purchase the article here.